SAT0086 Evaluation of diagnostic performance of magnetic resonance imaging (MRI) and ultrasound (US) toward early rheumatoid arthritis from nagasaki early arthritis cohort

A. Takatani, M. Tamai, N. Ohki, Y. Nakashima, Y. Endo, S. Tsuji, T. Shimizu, M. Umeda, S. Fukui, R. Sumiyoshi, A. Nishino, T. Koga (+10 others)
2018 Saturday, 16 JUNE 2018   unpublished
between anti-CarPA and DDAS28 showed association only with DDAS28 from baseline to M6 (p=0.005). In this period, the positive patients showed less decrease of DAS28 than the negative patients. This was independent of all the variables mentioned above and of the initial DAS28. As a result of this association, 20.5% of the anti-CarPA positive patients reached remission at M6, in comparison with 34.6% of the negative patients. In contrast, DDAS28 from M6 to M12 and from M12 to M24 were small and
more » ... t associated with anti-CarPA. Conclusions: Anti-CarPA were associated with high disease activity at presentation and with less improvement in the first 6 months of follow-up in EA patients. These results reinforce the possibility that anti-CarPA could be useful in the clinic as prognostic biomarkers.
doi:10.1136/annrheumdis-2018-eular.6534 fatcat:tnhyljp2srdsle6khe42bshbpm